Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)

NCT01382160 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
69
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Tours